NCT05387863

Decision Aid (DA) for Renal Patients

Evaluation of a Decision Aid in the Treatment Planning of Small Renal Tumors

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: NYU Langone Health · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to understand how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team will develop a decision aid (DA) using the decision-analytic model to communicate personalized benefit/harm estimates to patients and promote patient-centered treatment of renal tumors.

Conditions

• Kidney Tumor
• Renal Cancer

Interventions

Type	Name	Description
OTHER	Decision Aid (DA) Web Tool	The DA web tool provides information on kidney masses and available treatment options. It uses risk communication, directed teaching, and interactive benefit-harm assessment to present information.
OTHER	Institutional Pamphlet	The institutional pamphlet provides information on kidney masses, but does not use risk communication, directed teaching, or interactive benefit-harm assessment.

Timeline

• Start date: 2022-09-12
• Primary completion: 2026-06-01
• Completion: 2026-09-01
• First posted: 2022-05-24
• Last updated: 2025-12-02

Locations

1 site across 1 country: United States